Myriad Genetics, Inc.MYGNNASDAQ

Revenue (LTM)

$825M

-1.6% YoY

Net Income (LTM)

$-366M

-187.4% YoY

Free Cash Flow

$2M

Revenue CAGR (5Y)

+8.2%

—Marginsstable

FCFTurned positive

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	691	678↓1.8%	753↑11.0%	838↑11.2%	825↓1.6%
Gross Profit	493	476↓3.4%	517↑8.5%	585↑13.2%	577↓1.5%
Operating Income	-191	-141↑26.2%	-257↓83.1%	-124↑52.0%	-139↓12.8%
Net Income	-27	-112↓311.8%	-263↓135.1%	-127↑51.7%	-366↓187.4%
EBITDA	12	-85↓788.6%	-197↓133.1%	-60↑69.9%	-397↓567.9%
EPS Diluted	-0.35	-1.39↓297.1%	-3.18↓128.8%	-1.41↑55.7%	-3.96↓180.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	258	57↓78.0%	132↑132.2%	102↓22.5%	150↑46.1%
Total Current Assets	485	275↓43.4%	314↑14.2%	298↓5.0%	333↑11.6%
Total Assets	1,321	1,199↓9.2%	1,147↓4.4%	1,028↓10.4%	707↓31.2%
Total Current Liabilities	204	137↓32.8%	156↑13.6%	164↑5.3%	134↓18.5%
Total Liabilities	353	313↓11.3%	363↑16.1%	327↓10.1%	339↑3.7%
Total Equity	968	886↓8.5%	783↓11.6%	701↓10.5%	368↓47.5%
Total Debt	92	145↑57.1%	152↑4.9%	140↓7.8%	210↑49.5%
Net Debt	-166	88↑153.0%	20↓77.3%	38↑89.5%	60↑58.8%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	19	-106↓671.5%	-111↓4.3%	-9↑92.2%	2↑120.7%
Capital Expenditure	-18	-45↓151.7%	-73↓61.8%	-30↑59.5%	0
Free Cash Flow	1	-152↓25366.7%	-184↓21.5%	-38↑79.2%	2↑104.7%
Stock-Based Comp	36	38↑5.0%	41↑6.8%	50↑22.4%	0
Net Change in Cash	142	-192↓235.7%	75↑138.7%	-29↓138.9%	39↑235.9%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance